share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Caforio Giovanni

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Caforio Giovanni

施貴寶 | 4:持股變動聲明-高管 Caforio Giovanni
SEC announcement ·  03/13 05:44
牛牛AI助理已提取核心訊息
On March 10, 2024, Giovanni Caforio, Executive Chair of the Board at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Caforio acquired a total of 190,130 shares through the exercise or conversion of derivative securities at no cost. Concurrently, he disposed of 125,359 shares, with a portion of the disposals being used to cover exercise prices or tax liabilities at a price of $53.79 per share. The total market value of the disposed shares amounted to $3,648,199.17. Following these transactions, Caforio directly holds 432,266.333 shares of Bristol-Myers Squibb common stock.
On March 10, 2024, Giovanni Caforio, Executive Chair of the Board at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Caforio acquired a total of 190,130 shares through the exercise or conversion of derivative securities at no cost. Concurrently, he disposed of 125,359 shares, with a portion of the disposals being used to cover exercise prices or tax liabilities at a price of $53.79 per share. The total market value of the disposed shares amounted to $3,648,199.17. Following these transactions, Caforio directly holds 432,266.333 shares of Bristol-Myers Squibb common stock.
2024年3月10日,百時美施貴寶(BMY)董事會執行主席喬瓦尼·卡福里奧完成了一系列涉及公司普通股的交易。Caforio通過免費行使或轉換衍生證券共收購了190,130股股票。同時,他以每股53.79美元的價格出售了125,359股股票,其中一部分用於支付行使價或納稅義務。已處置股份的總市值爲3,648,199.17美元。在這些交易之後,Caforio直接持有432,266.333股百時美施貴寶普通股。
2024年3月10日,百時美施貴寶(BMY)董事會執行主席喬瓦尼·卡福里奧完成了一系列涉及公司普通股的交易。Caforio通過免費行使或轉換衍生證券共收購了190,130股股票。同時,他以每股53.79美元的價格出售了125,359股股票,其中一部分用於支付行使價或納稅義務。已處置股份的總市值爲3,648,199.17美元。在這些交易之後,Caforio直接持有432,266.333股百時美施貴寶普通股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。